Toxicology and pharmacology of botulinum and tetanus neurotoxins: an update.

Abstract

Tetanus and botulinum neurotoxins cause the neuroparalytic syndromes of tetanus and botulism, respectively, by delivering inside different types of neurons, metalloproteases specifically cleaving the SNARE proteins that are essential for the release of neurotransmitters. Research on their mechanism of action is intensively carried out in order to devise improved therapies based on antibodies and chemical drugs. Recently, major results have been obtained with human monoclonal antibodies and with single chain antibodies that have allowed one to neutralize the metalloprotease activity of botulinum neurotoxin type A1 inside neurons. In addition, a method has been devised to induce a rapid molecular evolution of the metalloprotease domain of botulinum neurotoxin followed by selection driven to re-target the metalloprotease activity versus novel targets with respect to the SNARE proteins. At the same time, an intense and wide spectrum clinical research on novel therapeutics based on botulinum neurotoxins is carried out, which are also reviewed here.

• Authors: Marco Pirazzini, Cesare Montecucco, Ornella Rossetto
• Journal: Archives of toxicology (Arch Toxicol) Vol. 96 Issue 6 Pg. 1521-1539 (06 2022) ISSN: 1432-0738 [Electronic] Germany
• PMID: 35333944 (Publication Type: Journal Article, Review)
• Copyright: © 2022. The Author(s).

Chemical References

• Neurotoxins
• SNARE Proteins
• Botulinum Toxins, Type A

Topics

• Botulinum Toxins, Type A (therapeutic use, toxicity)
• Clostridium botulinum (metabolism)
• Humans
• Neurotoxins (toxicity)
• SNARE Proteins
• Tetanus